We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00386633
Recruitment Status : Completed
First Posted : October 11, 2006
Last Update Posted : January 27, 2015
Information provided by:
Bavarian Nordic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : November 2007